Navigation Links
Amgen's Second Quarter 2013 Revenues Increased 5 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 3 Percent To $1.89
Date:7/30/2013

764764792791Diluted EPS

$ 3.52$ 3.85$ 3.09$ 3.44(*) Dilutive securities used to compute "Adjusted" diluted EPS for the three and six months ended June 30, 2013 and 2012 were computed under the treasury stock method assuming that we do not expense stock options(a)For the three and six months ended June 30, 2013, the total pre-tax expense for employee stock options was $7 million and $18 million, respectively, compared with $16 million and $32 million for the corresponding periods of the prior year"Adjusted" diluted EPS including the impact of stock option expense for the three and six months ended June 30, 2013 and 2012 was as follows:Three months endedSix months endedJune 30,June 30,2013201220132012"Adjusted" diluted EPS, excluding stock option expense

$ 1.89$ 1.83$ 3.85$ 3.44Impact of stock option expense (net of tax)

(0.01)(0.01)(0.02)(0.03)"Adjusted" diluted EPS, including stock option expense

$ 1.88$ 1.82$ 3.83$ 3.41(b)The adjustments in 2013 related primarily to non-cash amortization of intangible assets acquired in prior year business combinations. The adjustments in 2012 related primarily to non-cash amortization of intangible assets as well as retention and severance expenses(c)The adjustments in 2013 related primarily to non-cash amortization of intangible assets acquired in prior year business combinations. The adjustments in 2012 related primarily to transaction costs and non-cash amortization of intangible assets(d)The tax effect of the adjustments between our GAAP and "Adjusted" results takes into account the tax treatment and related tax rate(s) that apply to each adjustment in the applicable tax jurisdiction(s). Generally, this results in a tax impact at the U.S. marginal tax rate for certain adjustments, including the majority of amortization of intangible assets and non-cash interest expense associated with our convertible notes, whereas the tax impact of other adjustments, including stock option expense, depends
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Covance Reports Second Quarter Net Revenue of $592 Million, Pro Forma EPS of $0.78 and Record Adjusted Net Orders of $776 Million
2. Oncology remains most restrictive specialty for second year
3. China Biologic Products to Report Second Quarter 2013 Financial Results
4. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2013 Second Quarter Financial Results
5. Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
6. Webcast Alert: Isis Pharmaceuticals Second Quarter 2013 Financial Results Conference Call
7. VirtualScopics Schedules Second Quarter 2013 Earnings Announcement
8. Luminex Corporation Reports Second Quarter 2013 Results
9. Endo to Announce Second Quarter 2013 Financial Results on August 6, 2013
10. Simcere Pharmaceutical Group to Announce Second Quarter 2013 Financial Results on Tuesday, August 13, 2013
11. PDI, Inc. to Hold Second Quarter 2013 Financial Results Conference Call on Monday, August 5, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Sigma-Aldrich Corporation (NASDAQ: ... High Technology company, today announced the opening of ... and state-of-the-art Cell Culture Technical Center in Singapore.  ... provide customized support to meet customer needs, leveraging ... "Our new Technical Center will significantly enhance our ...
(Date:4/16/2015)... , April 16, 2015 A drug commonly ... eyesight of people with multiple sclerosis (MS), according to a ... Academy of Neurology,s 67th Annual Meeting in Washington, ... "About half of people with MS experience at some ... in which the nerve carrying vision from the eye to ...
(Date:4/16/2015)... , April 16, 2015 Today, Kenneth C. ... & Co., Inc., was elected chairman of the Board of ... Board meeting, PhRMA,s president and CEO John J. Castellani ... 2016.  New Officers Elected to PhRMA Board ... succeeds Ian C. Read , chairman and CEO of ...
Breaking Medicine Technology:Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 2Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 3Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 4Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 5Epilepsy Drug May Preserve Eyesight for People with MS 2Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 2Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 3Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 4Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 5
... BEDMINSTER, N.J. and SYDNEY, April 10, 2012 QRxPharma ... of two Phase 1 studies in healthy volunteers for ... of morphine and oxycodone. The proprietary MoxDuo CR formulation, ... deterrent and tamper resistant features, is designed to provide ...
... April 9, 2012  Legacy ® and Lung ... an actuarial cost-benefit analysis conducted by Milliman Inc., ... that screening 50-64 year olds at high risk ... scans can save more lives, and at lower cost ...
Cached Medicine Technology:QRxPharma Successfully Completes Phase 1 Studies for MoxDuo® CR 2QRxPharma Successfully Completes Phase 1 Studies for MoxDuo® CR 3QRxPharma Successfully Completes Phase 1 Studies for MoxDuo® CR 4Legacy® and Lung Cancer Alliance Hail the Release of New Study Showing Lung Cancer Screening is Cost Effective 2Legacy® and Lung Cancer Alliance Hail the Release of New Study Showing Lung Cancer Screening is Cost Effective 3
(Date:4/18/2015)... York (PRWEB) April 18, 2015 Thousand ... filed on behalf of individuals who were allegedly harmed ... continue to move forward in the U.S. District Court, ... April 10th, the Court has amended an earlier Case ... cases. Among other things, the new amendment permits the ...
(Date:4/18/2015)... More than 2000 styles of newly designed prom dresses ... store carrying celebrity inspired special occasion dresses. With the ... dresses for their prom. For those who are still ... would be an ideal choice. , "We have ... by the most loved styles seen at this years ...
(Date:4/18/2015)... Aureus Medical Group (web: aureusmedical.com), ... therapy jobs, has announced that it will participate ... Therapy Association Annual Conference to be held May ... SC. , The SCAPTA Annual Conference offers ... and services. , Representatives from Aureus Medical’s ...
(Date:4/18/2015)... 2015 PHOENIX, ARIZONA – In March, ... 11 other secure destruction professionals across the United States, ... He will now display “CSDS” as a professional title ... the National Association of Information Destruction 2015 Annual Conference ... Texas. Of the 20 people who took the exam, ...
(Date:4/17/2015)... Heritage Woods of McLeansboro, a Gardant affordable ... Celebration on April 20 with a day full of ... and soul. , The community, which is located at ... of all incomes, including those on Medicaid, who need ... Week is observed every April and highlights the communities ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 3Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3
... Board: HFIT), a leading provider of integrated,employee health and ... the B. Riley & Co. 9th Annual Las Vegas ... The Health Fitness,presentation is scheduled to begin at 10 ... the presentation will be Gregg Lehman, Ph.D.,president and chief ...
... ,Proud to be GI Awards, Honored for Commitment to Patient ... ... Today, Procter and Gamble,Pharmaceuticals (P&G) is encouraging GI and Endoscopy professionals ... through its support of the Society of Gastroenterology,Nurses and Associates, Inc. (SGNA) ...
... Malaria Therapy, written by WRAIR researchers Dr. Qugui Li, Dr. ... of Experimental Therapeutics at the WRAIR, Silver Spring, MD) provides ... in the treatment of one of the oldest and still ... , WRAIR, initially known as the Army Medical School, was ...
... Reports Record 2007 Revenue of $4.9 Million, an Increase of 126% ... -, - Removal ... ... Today at 4:15 p.m. ET -, DENVER, March 26 XELR8 Holdings, Inc. (Amex:,BZI), a ...
... 23 percent for moisture-barrier film, PHILADELPHIA, March 26 ... will expand production of Aclar(R) film to meet growing,demand ... pharmaceutical packaging., An upgrade of existing production capability, ... production by up to,23 percent by end of 2008 ...
... For decades, the American,Academy of Dermatology has advised ... cancer -- and that same advice holds true today,despite ... benefits of vitamin D are well known, it also ... cause skin cancer,",stated dermatologist C. William Hanke, MD, FAAD, ...
Cached Medicine News:Health News:Health Fitness to Present at B. Riley & Co. 9th Annual Las Vegas Investor Conference 2Health News:Nationwide Awards Recognize Nurses, Associates and Nursing Teams That Specialize in Gastroenterology and Endoscopy 2Health News:Nationwide Awards Recognize Nurses, Associates and Nursing Teams That Specialize in Gastroenterology and Endoscopy 3Health News:WRAIR investigators pioneering work on an exciting new class of antimalarial compounds 2Health News:XELR8 Holdings Announces Fiscal 2007 Financial Results 2Health News:XELR8 Holdings Announces Fiscal 2007 Financial Results 3Health News:XELR8 Holdings Announces Fiscal 2007 Financial Results 4Health News:XELR8 Holdings Announces Fiscal 2007 Financial Results 5Health News:XELR8 Holdings Announces Fiscal 2007 Financial Results 6Health News:XELR8 Holdings Announces Fiscal 2007 Financial Results 7Health News:XELR8 Holdings Announces Fiscal 2007 Financial Results 8Health News:Honeywell Expands Aclar(R) Production for Pharmaceutical Industry 2Health News:Honeywell Expands Aclar(R) Production for Pharmaceutical Industry 3Health News:American Academy of Dermatology Issues Statement Urging the Public to be Sun Smart(SM) 2
...
...
...
Solid blade speculum designed for both temporal and superior approach ocular surgery. Adjustable with thumb screw. Manufactured in titanium....
Medicine Products: